| P2093 | author name string | Tahiro Shin | |
| | Stephen D Miller | |
| | Lieping Chen | |
| | Samantha L Bailey | |
| | Bettina Schreiner | |
| P2860 | cites work | B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion | Q22010866 |
| | B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells | Q24291070 |
| | Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production | Q24292957 |
| | Human IL-17: a novel cytokine derived from T cells | Q24304404 |
| | The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice | Q24670319 |
| | Molecular modeling and functional mapping of B7-H1 and B7-DC uncouple costimulatory function from PD-1 interaction | Q24673269 |
| | Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation | Q24675931 |
| | T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines | Q24678115 |
| | Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor | Q28144319 |
| | Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice | Q28201627 |
| | PD-L2 is a second ligand for PD-1 and inhibits T cell activation | Q28202471 |
| | Expression of programmed death 1 ligands by murine T cells and APC | Q28214264 |
| | Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus | Q28250589 |
| | The expression and function of costimulatory molecules B7H and B7-H1 on colonic epithelial cells | Q28260674 |
| | Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes | Q28282689 |
| | Restoring function in exhausted CD8 T cells during chronic viral infection | Q28289222 |
| | IL-23 drives a pathogenic T cell population that induces autoimmune inflammation | Q29547525 |
| | A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 | Q29547855 |
| | Programmed death-1 concentration at the immunological synapse is determined by ligand affinity and availability | Q30480631 |
| | Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis | Q33835268 |
| | Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo | Q34049368 |
| | Experimental autoimmune encephalitis and inflammation in the absence of interleukin-12 | Q34145393 |
| | PD-1 inhibits antiviral immunity at the effector phase in the liver | Q34535179 |
| | Critical role of the programmed death-1 (PD-1) pathway in regulation of experimental autoimmune encephalomyelitis | Q34535189 |
| | Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells | Q34578170 |
| | PD-1/PD-L1, but not PD-1/PD-L2, interactions regulate the severity of experimental autoimmune encephalomyelitis | Q34593300 |
| | Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses | Q34650346 |
| | Fulminant spontaneous autoimmunity of the central nervous system in mice transgenic for the myelin proteolipid protein-specific T cell receptor | Q35111360 |
| | Insulin-induced remission in new-onset NOD mice is maintained by the PD-1-PD-L1 pathway. | Q36228158 |
| | Tissue expression of PD-L1 mediates peripheral T cell tolerance. | Q36228541 |
| | Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis | Q36365105 |
| | B7DC/PDL2 promotes tumor immunity by a PD-1-independent mechanism. | Q36370918 |
| | Cooperative B7-1/2 (CD80/CD86) and B7-DC costimulation of CD4+ T cells independent of the PD-1 receptor | Q36376676 |
| | In vivo costimulatory role of B7-DC in tuning T helper cell 1 and cytotoxic T lymphocyte responses | Q36402989 |
| | Local expression of B7-H1 promotes organ-specific autoimmunity and transplant rejection | Q36441358 |
| | Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. | Q36457107 |
| | The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection | Q36737159 |
| | PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells | Q36986702 |
| | Blockade of B7-H1 on macrophages suppresses CD4+ T cell proliferation by augmenting IFN-gamma-induced nitric oxide production | Q40395261 |
| | Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis. | Q40453661 |
| | Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand. | Q40460778 |
| | NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. | Q40493871 |
| | B7 family molecules are favorably positioned at the human maternal-fetal interface | Q40668007 |
| | Exacerbations of multiple sclerosis in patients treated with gamma interferon | Q40797798 |
| | Resident and infiltrating central nervous system APCs regulate the emergence and resolution of experimental autoimmune encephalomyelitis | Q40814343 |
| | B7-H1 restricts neuroantigen-specific T cell responses and confines inflammatory CNS damage: implications for the lesion pathogenesis of multiple sclerosis | Q44822884 |
| | Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice | Q45740050 |
| | Peripheral tolerance induction using ethylenecarbodiimide-fixed APCs uses both direct and indirect mechanisms of antigen presentation for prevention of experimental autoimmune encephalomyelitis | Q47581510 |
| | B7-H1 determines accumulation and deletion of intrahepatic CD8(+) T lymphocytes. | Q47926434 |
| | Regulation of PD‐1, PD‐L1, and PD‐L2 expression during normal and autoimmune responses | Q48186068 |
| | The neuronal chemokine CX3CL1/fractalkine selectively recruits NK cells that modify experimental autoimmune encephalomyelitis within the central nervous system | Q48554549 |
| | Microglial expression of the B7 family member B7 homolog 1 confers strong immune inhibition: implications for immune responses and autoimmunity in the CNS. | Q48974951 |
| | Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis. | Q49014751 |
| | Mice with a disrupted IFN-gamma gene are susceptible to the induction of experimental autoimmune encephalomyelitis (EAE). | Q52519041 |
| | CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4+ T(H)-17 cells in relapsing EAE. | Q53015646 |
| | Differential expression of PD-L1 and PD-L2, ligands for an inhibitory receptor PD-1, in the cells of lymphohematopoietic tissues. | Q53722655 |
| | T-cell clones specific for myelin basic protein induce chronic relapsing paralysis and demyelination. | Q53897545 |
| | De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. | Q53974447 |
| | Suppressed T-cell activation by IFN-gamma-induced expression of PD-L1 on renal tubular epithelial cells. | Q54702814 |
| | B7-DC regulates asthmatic response by an IFN-gamma-dependent mechanism | Q56903535 |
| | CTLA-4 downregulates epitope spreading and mediates remission in relapsing experimental autoimmune encephalomyelitis | Q56905834 |
| | Interferon-gamma in progression to chronic demyelination and neurological deficit following acute EAE | Q57042714 |
| | Blockade of CD28/B7-1 interaction prevents epitope spreading and clinical relapses of murine EAE | Q71457188 |
| | Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis | Q73330348 |
| | Endothelial expression of PD‐L1 and PD‐L2 down‐regulates CD8+ T cell activation and cytolysis | Q79209903 |
| | Mast cells enhance T cell activation: importance of mast cell costimulatory molecules and secreted TNF | Q82459138 |
| | Differential role of programmed death-ligand 1 [corrected] and programmed death-ligand 2 [corrected] in regulating the susceptibility and chronic progression of experimental autoimmune encephalomyelitis | Q82732353 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2706-2717 | |
| P577 | publication date | 2008-10-01 | |
| P1433 | published in | European Journal of Immunology | Q5412727 |
| P1476 | title | PD-1 ligands expressed on myeloid-derived APC in the CNS regulate T-cell responses in EAE. | |
| P478 | volume | 38 | |